메뉴 건너뛰기




Volumn 6, Issue 6, 2003, Pages 513-526

On the generation of novel anticancer drugs by recombinant DNA technology: The use of combinatorial biosynthesis to produce novel drugs

Author keywords

[No Author keywords available]

Indexed keywords

ACLACINOMYCIN; ACLARUBICIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; DACTINOMYCIN; DAUNORUBICIN; ELLORAMYCIN; JADOMYCIN B; LANDOMYCIN A; MITHRAMYCIN; MITOMYCIN C; NATURAL PRODUCT; NOGALAMYCIN; OLEANDOMYCIN; POLYKETIDE; PREMITHRAMYCINONE H; RABELOMYCIN; RHODOMYCIN A; TETRACENOMYCIN C; UNCLASSIFIED DRUG; UNINDEXED DRUG; URDAMYCIN B; URDAMYCIN C; URDAMYCIN F; URDAMYCIN I; URDAMYCIN J; URDAMYCIN K; URDAMYCIN M; URDAMYCIN N; URDAMYCIN O; URDAMYCINONE D;

EID: 0141513836     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620703106298699     Document Type: Review
Times cited : (26)

References (51)
  • 4
    • 0141846078 scopus 로고
    • Cancer chemotherapeutic agents
    • Washington, D.C. American, Chemical Society
    • Foye, W.O. Cancer chemotherapeutic agents. ACS Professional Reference Book. Washington, D.C. American, Chemical Society, 1995
    • (1995) ACS Professional Reference Book
    • Foye, W.O.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.